Registration of warrants of Series 2021/2026, incentive program
On 20 December 2021, the Extra General Meeting decided on the establishment of an incentive program for key personnel. The meeting resolved to issue a maximum of 75,000 warrants of Series 2021/2026.
A total of 65,000 warrants of series 2021/2026 were offered to key personnel, of which 100 percent were subscribed for. The warrants were registered with Bolagsverket on April 14, 2022.
Warrants were offered as follows:
| Name | Maximum number of options |
| CEO | 25 000 |
| Michael Malkoch Board member and acting CTO | 10 000 |
| Other key employees (3 persons) | 10 000 |
The option right may be exercised during the period 15 January 2026 to 31 January 2026. The subscription price amounts to SEK 20.94. The full terms of the warrants can be found on the Company’s website.
CEO Elin Mignérus comments
“We are very happy to announce that all key personnel wanted to participate fully in the warrants program. All of our employees are committed to making Polymer Factory a success, and we will continue to work hard to reach our goals. The aim of the incentive program was to engage the employees to be even more involved in the company’s journey, and to also share the success they are working hard to achieve.”
For more information about Polymer Factory, please contact:
Elin Mignérus, CEO
Phone: +46 (0) 79 300 27 76
E-mail: elin.mignerus@polymerfactory.com
Polymer Factory (publ) is a leading global provider and producer of dendritic materials, with customers ranging from BigPharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. The Company’s dendritic materials act as smart delivery systems that enhance the effects of the substances they carry, e.g. a vaccine or an anticancer drug. They have also shown great promise in diagnostics, tissue engineering and in the development of vaccines. In addition, Polymer Factory has used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments. The Company’s dendritic nanotechnologies have the potential to accelerate innovation in technologically demanding sectors, such as MedTech and BioTech. Learn more at www.polymerfactory.com.